ZYMIQ
LIVE

Serial Number

79400660

Owner

ZYMIQ Technology AB

Attorney

Karen Kreider Gaunt

Filing Date

Jun 13, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ZYMIQ Trademark

Serial Number: 79400660

ZYMIQ is a trademark filed by ZYMIQ Technology AB on June 13, 2024. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

ZYMIQ Technology AB (5 trademarks)

Medicon Village,

Entity Type: 98

Trademark Details

Filing Date

June 13, 2024

Registration Date

Not Registered

Goods & Services

Cosmetics; body cleaning and beauty care preparations, namely, body wash, body cream, non-medicated body soap, skin creams, skin lotions, skin moisturizers, and nonmedicated skin cleansing preparations; oral hygiene preparations, namely, non-medicated dental sprays; non-medicated skin care preparations; cosmetic preparations, non-medicated creams and lotions for skin care; non-medicated mouthwashes; mouth sprays being non-medicated mouth rinses, non-medicated mouth washes and non-medicated anti-cavity mouth rinses; dermatological creams and gels being non-medicated skin care preparations; dermatological creams and gels being non-medicated skin care preparations for pets and animals

Medical apparatus and instruments, namely, medical surgical apparatus and instruments for dental use for use in operating rooms and surgical theatres in hospitals, physician's offices, and medical facilities, and medical apparatus and instruments for surgical procedures utilizing anti-bacterial and anti-viral, and medical apparatus and instruments for use in mouth care and dental care; medical technical apparatus and instruments, for use in mouth care and dental care, namely, surgical apparatus and instruments for dental use

Pharmaceuticals and preparations for medical use, namely, pharmaceutical and medical preparations for the prevention of infections and bacteria-based diseases or disorders; hygienic preparations for medical use, namely, disinfectants for hygienic purposes and oral hygiene preparations for medical purposes in the nature of medicated oral care gels; anti-viral agents, namely, anti-viral disinfectants; anti-bacterial preparations, namely, antibacterial spray, antibacterial pharmaceuticals in the nature of antibiotics, antivirals and antifungals, and antibacterial cleansing and sterilizing preparations for medical use; nasal sprays for medical purposes; decongestant nasal sprays; throat sprays for medical purposes; medicated mouth care preparations; mouthwashes for medical purposes; medicated mouth spray; none of the aforesaid being or consisting of medicinal or medicated supplements or vitamins for use or ingestion by humans; creams and gels for dermatological use; creams and gels for dermatological use, for pets and animals; creams and gels for dermatological use, for veterinary purposes; medicated skin care preparations, creams and lotions for medical use; sanitary preparations for medical use and sanitary articles, namely, sanitary pads, sanitary towels, sanitary napkins, cloths impregnated with sanitary preparations for medical use, and sanitary cleansing solutions; disinfectants and antiseptics; dietary supplements and dietetic preparations for medical purposes; enzyme dietary supplements; enzymes and enzyme preparations for medical purposes not being or consisting of medicinal or medicated supplements or vitamins for ingestion by humans; enzymes and enzyme preparations for veterinary purposes.

Science and technology services, namely, scientific laboratory testing of materials, and chemical analysis services in the fields of pharmaceuticals and sanitary preparations, scientific research and scientific laboratory testing and analysis services in the fields of pharmaceuticals and sanitary preparations, and research and design in the field of medical technologies for application of pharmaceuticals and sanitary, anti-bacterial, anti-viral, and disinfectant preparations to medical procedures; medical and pharmacological research services; research related to medicine and pharmaceuticals; research related to life science; consultancy relating to research and development in the field of therapeutics; veterinary research

Filing History

WITHDRAWN FROM PUB - OG REVIEW QUERY
Jun 16, 2026 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
May 29, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 27, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 27, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 27, 2026 TROA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 8, 2026 OPNX
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 5, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jan 5, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jan 5, 2026 CNRT
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 24, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 24, 2025 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 10, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 10, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 10, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 23, 2025 GNFN
FINAL REFUSAL E-MAILED
Jul 23, 2025 GNFR
FINAL REFUSAL WRITTEN
Jul 23, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 2, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 2, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 2, 2025 TROA
REFUSAL PROCESSED BY IB
Feb 9, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 21, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jan 21, 2025 RFRR
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Jan 21, 2025 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Jan 10, 2025 LIMG
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 27, 2024 ADCH
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 24, 2024 RFCR
NON-FINAL ACTION WRITTEN
Dec 23, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 18, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 29, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 25, 2024 REPR